Biodesix Inc (BDSX) Stock Price, Quote & News

Company Profile

Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy,...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 303 417 0500

Fax: 866 432 3338

Website: www.biodesix.com

Address:

919 West Dillon Road, Louisville, United States

FreeBeerTomorrow Sep. 13 at 11:56 AM

$BDSX ** Biodesix, Inc. (BDSX) has a reverse stock split scheduled to become effective on Monday, September 15, 2025. The company announced a one-for-twenty (1-for-20) reverse stock split. The company stated that this action will decrease the number of outstanding shares from approximately 156 million to about 8 million.

0 · Reply

TwongStocks Sep. 12 at 8:38 PM

I am aware of three NASDAQ reverse splits on Monday. Expect trading to halt at 7:50pm ET tonight and resume at 9:00am ET Monday morning. $BDSX 1 for 20. Will reduce outstanding shares from approx 156m to approx 8m. $CLSD 1 for 15. Will reduce outstanding shares from approx 78.51m to approx 5.23m. $SDOT 1 for 10. Will reduce outstanding shares from approx 9.9m to approx 1m.

0 · Reply

Markmywordusee Sep. 12 at 5:59 PM

$BDSX

0 · Reply

simonsteve Sep. 12 at 2:06 PM

$BDSX what was all that CEO hype shit

0 · Reply

ballengerh2 Sep. 12 at 12:17 AM

$BDSX the buy back of stocks was an effort to see the stock jump to meet compliance. Prob made a deal and accepted eating the loss to try to trick us. Didn’t work, hit us with the RS instead. Duped.

0 · Reply

Ivythetiger Sep. 11 at 10:23 PM

$BDSX might it go .50 tomorrow 🏧

0 · Reply

simonsteve Sep. 11 at 10:11 PM

$BDSX if after RS this start to go back down you trick us to buy fuck you CEO 😆

0 · Reply

simonsteve Sep. 11 at 10:10 PM

$BDSX so the CEO buy back was a trick damn it

0 · Reply

TwongStocks Sep. 11 at 6:11 PM

$BDSX NASDAQ Equity Corporate Actions Alert # 2025 - 500 Information Regarding the Reverse Stock Split and CUSIP Number Change for Biodesix, Inc. (BDSX) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2025-500 Biodesix, Inc. (BDSX) will effect a one-for-twenty (1-20) reverse split of its Common Stock. The reverse stock split will become effective on Monday, September 15, 2025. In conjunction with the reverse split, the CUSIP number will change to 09075X207.

0 · Reply

tcwine Sep. 11 at 5:54 PM

$BDSX Maybe made a big deal with someone?

0 · Reply

Biodesix Announces One-for-Twenty Reverse Stock Split

Sep 5, 2025, 6:00 AM EDT - 9 days ago

Biodesix to Participate in Lake Street Capital Markets' 9th Annual Best Ideas Growth (BIG9) Conference

Aug 19, 2025, 9:47 AM EDT - 26 days ago

Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics

Aug 9, 2025, 11:07 AM EDT - 5 weeks ago

Biodesix, Inc. (BDSX) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:06 PM EDT - 5 weeks ago

Biodesix Announces Second Quarter 2025 Results and Highlights

Aug 5, 2025, 6:00 AM EDT - 5 weeks ago

Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference

Jul 24, 2025, 6:00 AM EDT - 7 weeks ago

Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025

Jun 10, 2025, 6:17 AM EDT - 3 months ago

Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs

May 22, 2025, 5:03 PM EDT - 4 months ago

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting

May 21, 2025, 6:00 AM EDT - 4 months ago

Biodesix to Participate in Upcoming Investor Conferences

May 15, 2025, 6:00 AM EDT - 4 months ago

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS

May 14, 2025, 4:01 PM EDT - 4 months ago

Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award

May 13, 2025, 8:22 PM EDT - 4 months ago

Biodesix, Inc. (BDSX) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:01 PM EDT - 4 months ago

Biodesix Announces First Quarter 2025 Results and Highlights

Apr 29, 2025, 6:00 AM EDT - 4 months ago

Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025

Apr 23, 2025, 6:00 AM EDT - 5 months ago

Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

Mar 3, 2025, 8:06 PM EST - 6 months ago

Biodesix, Inc. (BDSX) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 4:01 PM EST - 6 months ago

Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results

Feb 26, 2025, 6:00 AM EST - 7 months ago

Biodesix to Present at TD Cowen 45th Annual Health Care Conference

Feb 18, 2025, 6:00 AM EST - 7 months ago

Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Jan 10, 2025, 6:00 AM EST - 8 months ago

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)

Jan 7, 2025, 6:00 AM EST - 8 months ago

Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study

Nov 1, 2024, 3:29 PM EDT - 11 months ago

Biodesix, Inc. (BDSX) Q3 2024 Earnings Call Transcript

Nov 1, 2024, 6:00 AM EDT - 11 months ago

Biodesix Announces Third Quarter 2024 Results and Highlights

Oct 29, 2024, 6:00 AM EDT - 11 months ago

Biodesix to Participate in Three Investor Conferences in November

Oct 18, 2024, 6:00 AM EDT - 11 months ago

Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024

Oct 7, 2024, 6:00 AM EDT - 1 year ago

Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study

Sep 5, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Present at Two Investor Conferences in September

Aug 7, 2024, 8:52 PM EDT - 1 year ago

Biodesix, Inc. (BDSX) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 4:01 PM EDT - 1 year ago

Biodesix Announces Second Quarter 2024 Results and Highlights

Aug 6, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Present at Canaccord Genuity's 44th Annual Growth Conference

Jul 24, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024

Jun 18, 2024, 8:13 AM EDT - 1 year ago

Biodesix Named to Inc. Magazine's 2024 “Best Workplaces”

May 28, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Participate in Two Investor Conferences in June

May 21, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting

May 10, 2024, 1:06 AM EDT - 1 year ago

Biodesix, Inc. (BDSX) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:01 PM EDT - 1 year ago

Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management

May 7, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference

Apr 24, 2024, 6:00 AM EDT - 1 year ago

Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024

Apr 9, 2024, 5:00 PM EDT - 1 year ago

Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting

Apr 5, 2024, 7:17 AM EDT - 1 year ago

Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement

Mar 25, 2024, 6:00 AM EDT - 1 year ago

Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center

Mar 1, 2024, 12:35 PM EST - 1 year ago

Biodesix, Inc. (BDSX) Q4 2023 Earnings Call Transcript

Mar 1, 2024, 6:00 AM EST - 1 year ago

Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights

Feb 26, 2024, 6:00 AM EST - 1 year ago

Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference

Feb 16, 2024, 6:00 AM EST - 1 year ago

Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024

Nov 14, 2023, 6:00 AM EST - 1 year ago

Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method

Nov 11, 2023, 1:24 PM EST - 2 years ago

Biodesix, Inc. (BDSX) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 6:00 AM EST - 2 years ago

Biodesix to Participate in Two Upcoming Investor Conferences in November

Nov 7, 2023, 4:01 PM EST - 2 years ago

Biodesix Announces Third Quarter 2023 Results and Highlights

FreeBeerTomorrow Sep. 13 at 11:56 AM

0 · Reply

TwongStocks Sep. 12 at 8:38 PM

0 · Reply

Markmywordusee Sep. 12 at 5:59 PM

$BDSX

0 · Reply

simonsteve Sep. 12 at 2:06 PM

$BDSX what was all that CEO hype shit

0 · Reply

ballengerh2 Sep. 12 at 12:17 AM

0 · Reply

Ivythetiger Sep. 11 at 10:23 PM

$BDSX might it go .50 tomorrow 🏧

0 · Reply

simonsteve Sep. 11 at 10:11 PM

$BDSX if after RS this start to go back down you trick us to buy fuck you CEO 😆

0 · Reply

simonsteve Sep. 11 at 10:10 PM

$BDSX so the CEO buy back was a trick damn it

0 · Reply

TwongStocks Sep. 11 at 6:11 PM

0 · Reply

tcwine Sep. 11 at 5:54 PM

$BDSX Maybe made a big deal with someone?

0 · Reply

luckyCloud Sep. 11 at 5:14 PM

$BDSX what happened to Capital Markets’ 9th Annual Best Ideas Growth (BIG9) Conference

0 · Reply

Skeemzzz Sep. 11 at 4:20 PM

$BDSX $ILAG $PTNM $RBNE $SNTG this is a funny post.. you know ILAG jumped out of nowhere 40% right at close and is steadily creeping back up today. You can help me count my money when I cash out junior

0 · Reply

Bazzzigar Sep. 11 at 4:13 PM

$BDSX moved to AEMD

0 · Reply

ballengerh2 Sep. 11 at 3:55 PM

$BDSX should I cut losses or stay long? Can any good come of this. New to this and thought this was a good opportunity 🤷🏻‍♂️

1 · Reply

MyTummyHurts Sep. 11 at 3:38 PM

$BDSX ugh..

0 · Reply

simonsteve Sep. 11 at 3:17 PM

$BDSX I thought CEO bought 1.5M shares at 0.5 what happened did he sell

0 · Reply

stockanalysis_ Sep. 11 at 3:01 PM

Losers Today: $RBNE $SNTG $PTNM $ILAG $BDSX Save this screener here: https://stockanalysis.com/markets/losers/?ref=saveontrading

0 · Reply

tcwine Sep. 11 at 2:56 PM

$BDSX Major Holders Breakdown 52.13% % of Shares Held by All Insider 24.32% % of Shares Held by Institutions 50.80% % of Float Held by Institutions 44 Number of Institutions Holding Shares

0 · Reply

luckyCloud Sep. 11 at 2:30 PM

$BDSX after split outstanding shares around 7.3 million. Hopefully they shouldn't start diluting after RS. That would really screwed us up.

0 · Reply

ballengerh2 Sep. 11 at 1:05 PM

$BDSX we got played. Rough

0 · Reply

tcwine Sep. 11 at 12:43 PM

$BDSX Why did he buy more last week at a higher price ?? Independent Director Jack Schuler bought A additionalUS$1.5M worth of shares

2 · Reply

Df12221 Sep. 11 at 12:36 PM

$BDSX נבלות 🤮🤮🤮🤮

0 · Reply

Market Cap	55.00M
Revenue (ttm)	71.32M
Net Income (ttm)	-42.93M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-60.19%
Debt to Equity Ratio	41.05

Volume	3,536,300
Avg Vol	3,150,868
Day's Range	N/A - N/A
Shares Out	146.63M
Stochastic %K	12%
Beta	1.00
Analysts	Strong Sell
Price Target	$1.80